Nilgün GÜR, Levent RENDA, Nuray ENSARİ, Ömer Tarık SELÇUK, Yeşim ÇEKİN, Mehmet Türker ÖZTÜRK, Özer Erdem GÜR, Mustafa Deniz YILMAZ

Can apelin play a role in the etiology of tinnitus?

Background/aim: Tinnitus is seen in 15% of the general population; in 1%–6% of this number, the quality of life is seriously affectedby this chronic condition. Chemical, oxidative, and emotional stressors are important in terms of the clinical course of tinnitus. Apelinis an endogenous peptide which is an oxidative stress mediator. It has been shown that the apelin/APJ (apelin junction receptor) systemplays various roles in the physiology and pathophysiology of many organs. However, the role of the apelin/APJ system as an oxidativestress mediator in tinnitus is unknown. We investigated the level of apelin in patients with normal hearing and bilateral tinnitus.Materials and methods: We enrolled patients diagnosed with bilateral idiopathic tinnitus. Tinnitus severity was determined using thetinnitus handicap inventory (THI). We recorded the levels of plasma apelin-13 and biochemical parameters.Results: The mean apelin level of the control group was higher than that of the patient group (P = 0.002). A significant negativecorrelation was evident between the apelin level and the THI (r = –0.460, P = 0.003). The triglyceride (TG) level was significantly higherin the patient group than in the control group (P < 0.001).Conclusions: In our study, we found a negative correlation between apelin and tinnitus severity. Thus, apelin may play a role in thepathophysiology of idiopathic tinnitus, and may be prescribed during follow-up to reduce oxidative stress in the future. Further clinicalstudies on the effects of the apelin/APJ (apelin junction receptor) system and the effects of antioxidants in patients with inflammatorydiseases are required.

PDF

___

1. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am 2003; 36: 239-248.
2. Sindhusake D, Golding M, Wigney D, Newall P, Jakobsen K, Mitchell P. Factors predicting severity of tinnitus: a populationbased assessment. J Am Acad Audiol 2004; 15: 269-280.
3. Gilles A, Camp G V, Heyning P V, Fransen E. A pilot genomewide association study identifies potential metabolic pathways involved in tinnitus. Front Neurosci 2017; 11: 71. doi: 10.3389/ fnins.2017.00071.
4. Alpini D, Cesarani A. Tinnitus as an alarm bell: stress reaction tinnitus model. ORL J Otorhinolaryngol Relat Spec 2006; 68: 31-36.
5. O’Down BF, Heiber M, Chan A, Heng HHQ HH, Tsui LC, Kennedy JL, Shi XM, Petronis A. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome-11. Gene 1993; 136: 355-360.
6. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Bioph Res Co 1998; 251: 471-476.
7. Lu He, Jin Xu, Linxi Chen, Lanfang Li. Apelin/APJ signaling in hypoxia-related diseases. Clinica Chimica Acta 2015; 451, 191-198.
8. Zhou Y, Wang Y, and Qiao S. Apelin: a potential marker of coronary artery stenosis and atherosclerotic plaque stability in ACS patients. Int Heart J 2014; 55: 204-212.
9. Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt A, Mayranpaa M, Sarman B, Seres L, Skoumal R et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Bioph Res Co 2003; 308: 480-485.
10. Japp AG, Cruden NL, Amer DAB, Li VKY, Goudie EB, Johnston NR, Sharma S, Neilson I, Webb DJ, Megson IL et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol 2008; 52: 908-913.
11. Kawamata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538: 162-171.
12. Zhong JC, Zhang ZZ, Wang W, McKinnie SM, Vederas JC, Oudit GY. Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. Biochim Biophys Acta 2017 Aug; 1863: 1942-1950.
13. Zhou Q, Cao J, Chen L. Apelin/APJ system: a novel therapeutic target for oxidative stress-related inflammatory diseases (review). Int J Mol Med 2016; 37: 1159-1169.
14. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99: 87-92.
15. Yanga Y, Lva S-Y, Lyub S-K, Wua D, Yang QCY. The protective effect of apelin on ischemia/reperfusion injury. Peptides 2015 Jan; 63: 43-46.
16. Wu Y, Wang X, Zhou X, Cheng B, Li G and Bai B. Temporal expression of apelin/apelin receptor in ischemic stroke and its therapeutic potential. Front Mol Neurosci 2017; 10: 1.
17. Chen D, Lee J, Gu X, Wei L, and Yu SP. Intranasal delivery of apelin-13 is neuroprotective and promotes angiogenesis after ischemic stroke in mice. ASN Neuro 2015; 7: 1-15.
18. Neri S, Signorelli S, Pulvirenti D, Mauceri B, Cilio D, Bordonaro F, Abate G, Interlandi D, Misseri M, Ignaccolo L et al. Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus. Free Radic Res 2006; 40: 615-618.
19. Ciorba A, Bianchini C, Pastore A, Mazzoli M. Pathogenesis of tinnitus: any role for oxidative stress? Int Adv Otol 2013; 9: 249-254.
20. Gilles A, Ihtijarevic B, Wouters K, Heyning PV. Using prophylactic antioxidants to prevent noise-induced hearing damage in young adults: a protocol for a double-blind, randomized controlled trial. Trials 2014; 15: 110.